{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T22:42:53Z","timestamp":1661899373405},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Carl Gustav Carus Dresden an der Technischen Universit\u00e4t Dresden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Wir berichten \u00fcber einen 48-j\u00e4hrigen multimorbiden Patienten, der vor 26\u00a0Jahren eine allogene Knochenmarktransplantation aufgrund einer chronischen myeloischen Leuk\u00e4mie erhielt; 24\u00a0Jahre lang litt der Patient an einer sklerodermiformen chronischen Graft-versus-Host-Disease (GVHD) der Haut und der Lunge mit partieller Lungenresektion und immunsuppressiver Therapie. An den Unterschenkeln entwickelten sich rezidivierende Ulzerationen an den von der kutanen GVHD betroffenen Stellen. Der Patient stellte sich mit einem gr\u00f6\u00dfenprogredienten Ulkus mit Therapieresistenz in unserer Klinik vor. Histologisch konnte ein Plattenepithelkarzinom diagnostiziert werden. Die Magnetresonanztomographie zeigte eine Knochenbeteiligung und eine kutane In-Transit-Metastase, und die Computertomographie ergab eine Metastase im Os sacrum. Bevor die Therapie eingeleitet wurde, verstarb der Patient pl\u00f6tzlich an den Folgen seiner Vorerkrankungen. Die Entwicklung einer kutanen GVHD ist h\u00e4ufig bei Patienten mit allogener Stammzelltransplantation. Hierbei ist das Risiko f\u00fcr die Entwicklung von Plattenepithelkarzinomen erh\u00f6ht. Patienten sollten unter engmaschiger dermatologischer Kontrolle stehen. Bei Verdacht auf ein Plattenepithelkarzinom bei vorbestehender GVHD sollte zeitnah eine bioptische Sicherung erfolgen, um das Risiko einer Metastasierung zu senken.<\/jats:p>","DOI":"10.1007\/s00105-021-04932-z","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T13:02:40Z","timestamp":1641387760000},"page":"722-726","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metastasiertes Plattenepithelkarzinom auf einem Ulkus bei Graft-versus-Host-Disease nach allogener Stammzelltransplantation"],"prefix":"10.1007","volume":"73","author":[{"given":"S.","family":"Hobelsberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Beissert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"4932_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamadermatol.2015.121","volume":"151","author":"JL DePry","year":"2015","unstructured":"DePry\u00a0JL, Vyas\u00a0R, Lazarus\u00a0HM et\u00a0al (2015) Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol 151:775\u2013782. https:\/\/doi.org\/10.1001\/jamadermatol.2015.121","journal-title":"JAMA Dermatol"},{"key":"4932_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","volume":"19","author":"K Strong Rodrigues","year":"2018","unstructured":"Strong Rodrigues\u00a0K, Oliveira-Ribeiro\u00a0C, de Abreu Fiuza Gomes\u00a0S et al (2018) Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol 19:33\u201350. https:\/\/doi.org\/10.1007\/s40257-017-0306-9","journal-title":"Am J Clin Dermatol"},{"key":"4932_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1590\/abd1806-4841.20164180","volume":"91","author":"CDV Villarreal","year":"2016","unstructured":"Villarreal\u00a0CDV, Alanis\u00a0JCS, P\u00e9rez\u00a0JCJ et al (2016) Cutaneous graft-versus-host disease after hematopoietic stem cell transplant\u2014a\u00a0review. An Bras Dermatol 91:336\u2013343. https:\/\/doi.org\/10.1590\/abd1806-4841.20164180","journal-title":"An Bras Dermatol"},{"key":"4932_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.hemonc.2013.02.006","volume":"6","author":"C Mittal","year":"2013","unstructured":"Mittal\u00a0C, Hassan\u00a0S, Mattour\u00a0A et\u00a0al (2013) Metastatic squamous cell carcinoma in a\u00a0bone marrow transplant recipient. Hematol Oncol Stem Cell Ther 6:46\u201347. https:\/\/doi.org\/10.1016\/j.hemonc.2013.02.006","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"4932_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","volume":"124","author":"G Soci\u00e9","year":"2014","unstructured":"Soci\u00e9\u00a0G, Ritz\u00a0J (2014) Current issues in chronic graft-versus-host disease. Blood 124:374\u2013384. https:\/\/doi.org\/10.1182\/blood-2014-01-514752","journal-title":"Blood"},{"key":"4932_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jaad.2018.01.012","volume":"79","author":"PH Rambhia","year":"2018","unstructured":"Rambhia\u00a0PH, Conic\u00a0RZ, Atanaskova-Mesinkovska\u00a0N et al (2018) Role of graft-versus-host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: a meta-analysis. J\u00a0Am Acad Dermatol 79:378\u2013380.e3. https:\/\/doi.org\/10.1016\/j.jaad.2018.01.012","journal-title":"J Am Acad Dermatol"},{"key":"4932_CR7","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","volume":"105","author":"RE Curtis","year":"2005","unstructured":"Curtis\u00a0RE, Metayer\u00a0C, Rizzo\u00a0JD et al (2005) Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 105:3802\u20133811. https:\/\/doi.org\/10.1182\/blood-2004-09-3411","journal-title":"Blood"},{"key":"4932_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbmt.2018.08.028","volume":"25","author":"A Ijaz","year":"2019","unstructured":"Ijaz\u00a0A, Khan\u00a0AY, Malik\u00a0SU et al (2019) Significant risk of graft-versus-host disease with exposure to checkpoint inhibitors before and after allogeneic transplantation. Biol Blood Marrow Transplant 25:94\u201399. https:\/\/doi.org\/10.1016\/j.bbmt.2018.08.028","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04932-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04932-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04932-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T22:14:18Z","timestamp":1661897658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04932-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["4932"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04932-z","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"8 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Hobelsberger, F.\u00a0Meier, S.\u00a0Beissert und S.\u00a0Abraham geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}